Correction to: Efficacy of oral rosuvastatin intervention on HDL and its associated proteins in men with type 2 diabetes
- PDF / 190,635 Bytes
- 1 Pages / 595.276 x 790.866 pts Page_size
- 72 Downloads / 174 Views
CORRECTION
Correction to: Efficacy of oral rosuvastatin intervention on HDL and its associated proteins in men with type 2 diabetes mellitus Sriram Naresh1 Aparna R. Bitla1 P. V. L. N. Srinivasa Rao1 Alok Sachan2 Yadagiri Lakshmi Amancharla3 ●
●
●
●
© Springer Science+Business Media, LLC, part of Springer Nature 2020
1234567890();,:
1234567890();,:
Correction to: Endocrine https://doi.org/10.1007/s12020-020-02472-5 The original version of this article unfortunately contained a mistake in “Results” section. The sentence “Majority of the study participants; n = 38 (95.0%) were on treatment with metformin while only one each (2.5%) were on glycomet and on ayurvedic treatment
The original article can be found online at https://doi.org/10.1007/ s12020-020-02472-5. * Aparna R. Bitla [email protected] 1
Department of Biochemistry, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh 517507, India
2
Department of Endocrinology and Metabolism, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh 517507, India
3
Department of Radiology, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh 517507, India
at the time of recruitment”. should read as “Majority of the study participants; n = 39 (97.0%) were on treatment with metformin while only one (3%) was on ayurvedic treatment at the time of recruitment”. The original article has been corrected. Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Data Loading...
